Anti-PGK1 antibodies in immuno-related pancytopenia
Detecting anti-PGK1 antibodies might have some clinical value in differentiating IRP from SAA. The tests of CD34+ IgM positivity, CD5+ B cells, and C3 and C4 levels are of clinical value in assessing the curative effect of IRP patients.
Authors
- Shanfeng Hao (ORCID: https://orcid.org/0000-0003-4487-2997)
- Rong Fu (ORCID: https://orcid.org/0000-0002-2850-1697)
- Zonghong Shao
- Yang Zhang (ORCID: https://orcid.org/0000-0002-2739-1916)
- Na Xiao (ORCID: https://orcid.org/0000-0003-3129-2467)
Institutions
- Tianjin Medical University General Hospital (CN)
Publication Details
- Journal
- Hematology
- Published
- 2025-02-26
- DOI
- https://doi.org/10.1080/16078454.2025.2468565
- Primary Topic
- Immunodeficiency and Autoimmune Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00